SLC6A14 and cystic fibrosis: Moreover, genome-wide association studies has recently identified SLC6A14/ATB0,+ as a genetic modifier of lung disease severity in cystic fibrosis, providing a mechanism by which it regulates Pseudomonas aeruginosa attachment to human bronchial epithelial cells [40].